Skip to main content
Clinical Trials/IRCT201612262365N16
IRCT201612262365N16CompletedPhase 3

The effects of Red Beetroot (Beta vulgaris L.) consumption on insulin sensitivity index ( HOMA-IR) metabolic profile, total anti-oxidant capacity, inflammation and cognitive performance in patients with type 2 diabetes

Iran University Of Medical Sciences0 sites45 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
45

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30 years to 65 years (—)
Sex
All

Inclusion Criteria

  • patient satisfaction; Diagnosis of type II diabetes (fasting blood glucose greater than or equal to 126 mg / dl or the2hpp l 200 mg / d, or random blood sugar over 200); HbA1c above 6.5% and below 8.5%; At least one year history of diabetes; TG <250 mg / dl; BMI< 35 kg / m²; Age 30 to 65 years; Patients not previously participate in any research project. Exclusion criteria: insulin injections; Hyperglycemia attacks in the past year that have led to hospitalization; Use of tobacco and alcohol; The risk of cardiovascular diseases, liver and kidney and hypothyroid; Taking antidepressants; The use of any supplemental antioxidant vitamins to 3 months; being pregnant or lacting; NSAID's use of nonsteroidol anti-inflammatory drug; The emergence of any problems or sensitivity at any time during the study; Non-adherence to treatment (less than 80% or less than 48 days); The occurrence of any patient intervention; Unwillingness to cooperate; Changing drug program (injected insulin).

Exclusion Criteria

  • Not provided

Investigators

Similar Trials